Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study
Authors:
- Rachel L RandellRRRachel L Randell
- Ajay S GulatiAGAjay S Gulati
- Suzanne F CookSCSuzanne F Cook
- Christopher F MartinCMChristopher F Martin
- Wenli ChenWCWenli Chen
- Elizabeth L JaegerEJElizabeth L Jaeger
- Alexi A SchoenbornASAlexi A Schoenborn
- Patricia V BastaPBPatricia V Basta
- Hendrik DejongHDHendrik Dejong
- Jingchun LuoJLJingchun Luo
- Marisa GallantMGMarisa Gallant
- Robert S SandlerRSRobert S Sandler
Open Access
- 5 January 2016
- journal article
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 5 (1) , e3
Abstract
The Internet has successfully been used for patient-oriented survey research. Internet-based translational research may also be possible. Our aim was to study the feasibility of collecting biospecimens from CCFA Partners, an Internet-based inflammatory bowel disease (IBD) cohort. From August 20, 2013, to January 4, 2014, we randomly sampled 412 participants, plus 179 from a prior validation study, and invited them to contribute a biospecimen. Participants were randomized to type (blood, saliva), incentive (none, US $20, or US $50), and collection method for blood. The first 82 contributors were also invited to contribute stool. We used descriptive statistics and t tests for comparisons. Of the 591 participants, 239 (40.4%) indicated interest and 171 (28.9%) contributed a biospecimen. Validation study participants were more likely to contribute than randomly selected participants (44% versus 23%, P<.001). The return rate for saliva was higher than blood collected by mobile phlebotomist and at doctors' offices (38%, 31%, and 17% respectively, P<.001). For saliva, incentives were associated with higher return rates (43-44% versus 26%, P=.04); 61% contributed stool. Fourteen IBD-associated single nucleotide polymorphisms were genotyped, and risk allele frequencies were comparable to other large IBD populations. Bacterial DNA was successfully extracted from stool samples and was of sufficient quality to permit quantitative polymerase chain reaction for total bacteria. Participants are willing to contribute and it is feasible to collect biospecimens from an Internet-based IBD cohort. Home saliva kits yielded the highest return rate, though mobile phlebotomy was also effective. All samples were sufficient for genetic testing. These data support the feasibility of developing a centralized collection of biospecimens from this cohort to facilitate IBD translational studies.Keywords
This publication has 38 references indexed in Scilit:
- Challenges in IBD ResearchInflammatory Bowel Diseases, 2013
- Environmental Factors and Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Environmental Triggers for Inflammatory Bowel DiseaseCurrent Gastroenterology Reports, 2012
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US PopulationDigestive Diseases and Sciences, 2012
- Crucial steps in the natural history of inflammatory bowel diseaseWorld Journal of Gastroenterology, 2012
- Utilization of healthcare resources by U.S. children and adults with inflammatory bowel diseaseInflammatory Bowel Diseases, 2011
- Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and AdultsGastroenterology, 2008
- Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseasesJournal of Internal Medicine, 2008
- The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United StatesClinical Gastroenterology and Hepatology, 2007